(Q50644127)

17 March 2018

title

Long-term follow-up of a randomized trial of interferon therapy for chronic hepatitis B in a predominantly homosexual male population. (English)

1 reference

17 March 2018

1 reference

Chen DK

1

1 reference

17 March 2018

Yim C

2

1 reference

17 March 2018

O'Rourke K

3

1 reference

17 March 2018

Krajden M

4

1 reference

17 March 2018

Wong DK

5

1 reference

17 March 2018

Heathcote EJ

6

1 reference

17 March 2018

publication date

1 April 1999

1 reference

17 March 2018

published in

Journal of Hepatology

1 reference

17 March 2018

volume

30

1 reference

17 March 2018

issue

4

1 reference

17 March 2018

page(s)

557-563

1 reference

17 March 2018

The development of cirrhosis in patients with chronic type B hepatitis: A prospective study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Hepatitis B virus. The major etiology of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

The interaction of human immunodeficiency virus infection and hepatitis B virus infection in infected homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Histological improvement after anti-viral treatment for chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Interferon alfa treatment of chronic hepatitis B: Randomized trial in a predominantly homosexual male population

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Interferon treatment of viral hepatitis in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Alpha-interferon therapy of chronic hepatitis B. Current status and recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Long-term remission of chronic hepatitis B after alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Long-term follow-up of chronic hepatitis B patients treated with interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Long-term effects of interferon-alpha in five HIV-positive patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Repeated courses of alpha-interferon for treatment of chronic hepatitis type B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-alpha and zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Hepatitis B in patients with HIV infection: relationship to AIDS and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Association of hepatitis B surface antigen and core antibody with acquisition and manifestations of human immunodeficiency virus type 1 (HIV-1) infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Progression to AIDS and predictors of AIDS in seroprevalent and seroincident cohorts of homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti-HBe induced spontaneously or with interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980184-6

7 January 2021

10.1016/S0168-8278(99)80184-6

Identifiers

DOI

1 reference

17 March 2018

PubMed ID

10207795

1 reference

17 March 2018